Brean Murray Upgrades CardioNet (BEAT) to Buy; Valuation Compelling Enough, Given Risk/Reward
Tweet Send to a Friend
Brean Murray upgrades CardioNet (Nasdaq: BEAT) to Buy. Price target $14.
Brean analyst says, "Two potential catalysts coming ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Brean analyst says, "Two potential catalysts coming ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
